Diadexus vi invita al simposio “Lipoprotein Associated Phosholipase A2 (Lp-PLA2): A New Risk Factor for Cardiovascular Disease”
Date: 01-Sep-2014 (6:00-8:00 pm)
HOTEL FIRA CONGRESS – MEETING ROOM Nº 3
José Agustín Goytisolo, 9-11
Hospitalet de Llobregat (Barcelona)
Clinical Utilization of Lp-PLA2 in Cardiovascular Disease Risk Assessment
Amir Lerman, Professor of Medicine
Mayo Clinic College of Medicine
Prof. Lerman is the Director for the Center of Coronary Physiology & Imaging as well as the Chest Pain & Coronary Physiology Clinic. He has been involved in CV research in CAD and imaging as well as in the development and application of invasive and non-invasive CV imaging for over 20 years. He is the principal investigator on several NIH grants addressing the effect of inflammation and endothelial progenitor cells on vascular aging, function and structure and is the author of more than 350 papers in this area.
Relationships of Lp-PLA2 with Other Cardiovascular Risk Factors
Ernst Schaefer, MD, Chief Medical Officer
Boston Heart Diagnostics
Distinguished University Professor, Tufts University
Framingham, MA, USA
Dr. Schaefer received his B.A. cum laude (biology) from Harvard University, his B.M.S. from Dartmouth Medical School, and his M.D. from Mount Sinai School of Medicine. Dr. Schaefer is an author or co-author of over 500 publications and served on the first and second adult treatment panels of the NCEP, on the Nutrition Study Section, the Metabolism Study Section, the Clinical Research Sections of the NIH, and the Nutrition Committee of the AHA.
Impact of a combined red yeast rice and olive extract supplement in lowering CVD Results of a double blind study
Annelies Breynaert, Doctor Pharmacology
Faculty of Pharmaceutical and Biomedical Sciences
University of Antwerp, Belgium
Dr. Breynaert is a research member of the Natural Products and Food – Research and Analysis (NatuRA) Research Unit at the University of Antwerp. NatuRA combines the complementary expertise of three research teams at the University of Antwerp: Pharmaceutical Analysis, Pharmacognosy, and Nutrition and Functional Food Science. The mission of NatuRA is to develop phytotherapeutics and nutraceuticals and to prove the activity of existing food supplements.
To RSVP for this event, please contact Linda Umbertus at 1-650-246-2428 or email email@example.com